Follow
Ery Setiawan
Ery Setiawan
University of Indonesia
Verified email at cheps.or.id
Title
Cited by
Cited by
Year
Economic burden of dengue in Indonesia
M Nadjib, E Setiawan, S Putri, J Nealon, S Beucher, SR Hadinegoro, ...
PLoS neglected tropical diseases 13 (1), e0007038, 2019
572019
Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis
C Mulder, S Rupert, E Setiawan, E Mambetova, P Edo, J Sugiharto, ...
BMJ global health 7 (1), e007182, 2022
222022
How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making
S Botwright, AL Kahn, R Hutubessy, P Lydon, J Biey, AK Sidibe, I Diarra, ...
Vaccine: X 6, 100078, 2020
132020
Cost and affordability of scaling up tuberculosis diagnosis using Xpert MTB/RIF testing in West Java, Indonesia
M Nadjib, RK Dewi, E Setiawan, TY Miko, S Putri, PF Hadisoemarto, ...
PloS one 17 (3), e0264912, 2022
112022
A Comparative Budget Requirements for TB program based on Minimum standard of Services (SPM) and Budget Realization: an Exit Strategy Before Termination of GF ATM
E Setiawan, PK Sucahya, H Thabrany, K Komaryani
Jurnal Ekonomi Kesehatan Indonesia 1 (1), 2016
92016
Kinerja Rumah Sakit Swasta dengan Pembayaran INA-CBGs di Era Jaminan Kesehatan Nasional: Casemix, Casemix Index, Hospital Base Rate
A Nurwahyuni, E Setiawan
Jurnal Ekonomi Kesehatan Indonesia 4 (2), 1-10, 2019
72019
Ketidaktepatan Sasaran Jaminan Kesehatan Masyarakat Berdasarkan Kriteria Miskin Pendataan Program Perlindungan Sosial”. Kesmas
U Lutfiah, E Setiawan, SS Lucia
Jurnal Kesehatan Masyarakat Nasional Vol 9, 362-368, 2015
72015
Kajian literatur sistematis: skema pengendalian biaya dalam asuransi kesehatan nasional di beberapa negara
E Pujiyanti, E Setiawan, ER Sari, IP Suwandi
Jurnal Ekonomi Kesehatan Indonesia 4 (2), 2020
32020
Predicting the cost of COVID-19 treatment and its drivers in Indonesia: analysis of claims data of COVID-19 in 2020-2021
RR Nugraha, MA Pratiwi, RE Al-Faizin, AB Permana, E Setiawan, ...
Health Economics Review 12 (1), 45, 2022
22022
Utilization patterns of healthcare facility and estimated expenditure of PLHIV care under the Indonesian National Health Insurance Scheme in 2018
E Setiawan, N Nurjannah, K Komaryani, RR Nugraha, H Thabrany, ...
BMC Health Services Research 22 (1), 97, 2022
22022
Tuberculosis in Indonesia: epidemic projections and opportunities to accelerate control: findings from an optima TB analysis
P Harimurti, E Pradhan, N Cheikh, R Hafez, N Fraser-Hurt, MN Farid, ...
World Bank Group, 2020
22020
Drug use pattern in dengue patients who visited hospitals and primary health center in Yogyakarta, Indonesia
E Kristin, A Yasmina, RT Pinzon, WR Pratiwi, C Trijayanti, E Setiawan, ...
Journal of Pharmaceutical Sciences and Research 10 (8), 2065-2068, 2018
22018
Adding rituximab to chemotherapy for diffuse large B-cell lymphoma patients in Indonesia: a cost utility and budget impact analysis
S Putri, E Setiawan, SRF Saldi, LC Khoe, ER Sari, A Megraini, M Nadjib, ...
BMC Health Services Research 22 (1), 553, 2022
12022
Narrowing the gap of inequity in the Indonesia’s National Social Health Insurance Scheme, 2014-2018
H Thabrany, RR Nugraha, E Setiawan, F Purwaningrum
12021
Biaya, Pembiayaan & Efektifitas Biaya di Bidang Kesehatan Masyarakat
M Nadjib, E Setiawan
Universitas Indonesia Publishing, 2020
12020
Rancang Bangun Alat Bantu Untuk Pengelasan Siku, T dan Sejajar untuk Praktikum Teknik Pengelasan
GJ Ismoyoaji, A Jihan, E Setiawan, BW Sidharta
Jurnal Teknik Mesin 3 (1), 24-31, 2016
12016
Ketidaktepatan Sasaran Jamkesmas Berdasarkan Kriteria Miskin Pendataan Program Perlindungan Sosial
U Luthfiah, E Setiawan, SS Lucia
Kesmas: Jurnal Kesehatan Masyarakat Nasional (National Public Health Journal …, 2015
12015
Inaccuracy of Public Health Insurance Target Based on Poor Criteria of Data Collection for Social Protection Program
U Lutfiah, E Setiawan, SS Lucia
KESMAS-NATIONAL PUBLIC HEALTH JOURNAL 9 (4), 362-368, 2015
12015
PELAYANAN KESEHATAN PRIMER SEBAGAI GATEKEEPER DAN KEBIJAKAN DISKUSI PEER REVIEW: ANTARA KUALITAS DAN REALITAS UNTUK MENURUNKAN KASUS RUJUKAN NON SPESIALISTIK
Z Zahrina, RV Ramadani, KN il Hulwah, S Nurlatifah, A Andalan, A Gani, ...
Jurnal Ekonomi Kesehatan Indonesia 8 (2), 142-153, 2023
2023
Cetuximab as first-line treatment for metastatic colorectal cancer (mCRC): a model-based economic evaluation in Indonesia setting
S Putri, SRF Saldi, LC Khoe, E Setiawan, A Megraini, B Santatiwongchai, ...
BMC cancer 23 (1), 731, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20